Top Markets
Coin of the day
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
株式のランク #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
株価
$0.60736143
時価総額
$58.28M
変化(1日)
-1.04%
変化(1年)
-21.09%
TW
取引 Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

カテゴリー

Gwo Xi Stem Cell Applied Technology Co. , Ltd(6704)の株式分割履歴
Gwo Xi Stem Cell Applied Technology Co. , Ltd株(シンボル:6704)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 21, 2026に行われました。
Aug 21, 2026より前に購入された6704株は、現在06704株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH